Skip to main content
. 2020 Jan 27;10:1243. doi: 10.1038/s41598-019-57321-x

Figure 2.

Figure 2

Recurrence-free survival (PFS) and overall survival (OS) curves according to neutrophil-to-lymphocyte ratio (NLR) and tumor proportion score (TPS) for tumoral PD-L1 expression status. The cut-off value for NLR and TPS were 2.2 and 1, respectively.